JPET #163493 1 Role of Basic Residues Within or Near the Predicted Transmembrane Helix 2 of the Human Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantrone.

  2010cited by this paper
• Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

  2009influential reference
• Application of the PM6 method to modeling proteins

  2009influential reference
• Natural Allelic Variants of Bovine ATP-Binding Cassette Transporter ABCG2: Increased Activity of the Ser581 Variant and Development of Tools for the Discovery of New ABCG2 Inhibitors

  2009influential reference
• Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock

  2009cited by this paper
• Arginine 383 is a crucial residue in ABCG2 biogenesis.

  2009cited by this paper
• ABCG2: a perspective.

  2009influential reference
• Membrane topology of the human breast cancer resistance protein (BCRP/ABCG2) determined by epitope insertion and immunofluorescence.

  2008influential reference
• Interaction with the 5D3 Monoclonal Antibody Is Regulated by Intramolecular Rearrangements but Not by Covalent Dimer Formation of the Human ABCG2 Multidrug Transporter*

  2008influential reference
• Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity.

  2007cited by this paper
• A semiempirical free energy force field with charge‐based desolvation

  2007influential reference
• Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization.

  2006cited by this paper
• The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding

  2006cited by this paper
• Purification of breast cancer resistance protein ABCG2 and role of arginine-482

  2006cited by this paper
• Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter

  2006cited by this paper
• Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2.

  2006cited by this paper
• Functional Importance of Three Basic Residues Clustered at the Cytosolic Interface of Transmembrane Helix 15 in the Multidrug and Organic Anion Transporter MRP1 (ABCC1)*

  2006influential reference
• Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.

  2005cited by this paper
• Role of the breast cancer resistance protein (ABCG2) in drug transport

  2005cited by this paper
• Mutations

  2004influential reference
• Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding.

  2004cited by this paper
• Functional expression of the human breast cancer resistance protein in Pichia pastoris.

  2004cited by this paper
• Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2*

  2004cited by this paper
• Identification of Proline Residues in the Core Cytoplasmic and Transmembrane Regions of Multidrug Resistance Protein 1 (MRP1/ABCC1) Important for Transport Function, Substrate Specificity, and Nucleotide Interactions*

  2004cited by this paper
• A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport.

  2003influential reference
• Functional and structural consequences of cysteine substitutions in the NH2 proximal region of the human multidrug resistance protein 1 (MRP1/ABCC1).

  2003influential reference
• Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants

  2003influential reference
• Functional characterization of human breast cancer resistance protein (BCRP, ABCG2) expressed in the oocytes of Xenopus laevis.

  2003cited by this paper
• Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

  2001cited by this paper
• Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells.

  2001influential reference
• A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).

  2001cited by this paper
• Identification of Basic Residues Involved in Drug Export Function of Human Multidrug Resistance-associated Protein 2*

  2000influential reference
• Helical membrane protein folding, stability, and evolution.

  2000cited by this paper
• Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

  1999cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998cited by this paper
• Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein.

  1997influential reference
• Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page

  year unknowncited by this paper

• Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport.

  2010cites this paper